Clinical trial
Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
NCT01644669
Study timeline
Study start (actual)2012-05-08Date precision: day
Registry last updated2025-01-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Invasive Ductal Carcinomaunresolved
Ductal Carcinoma in Situunresolved
Interventions
Sponsors & collaborators
Xoft, Inc.lead sponsor
Icad, Inc.collaborator
Mapped research locations
BaltimoreMaryland, United States3ChicagoIllinois, United States1Los AngelesCalifornia, United States1NashvilleTennessee, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1TucsonArizona, United States1Long BeachCalifornia, United States1DuarteCalifornia, United States1ChattanoogaTennessee, United States1PortoPortugal1Staten IslandNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01644669 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.